Wood is a urologic oncology fellow at Glickman Urological & Kidney Institute at the Cleveland Clinic in Ohio.
iRARC adoption is slow but persistent in bladder cancer
"Over the past 10 to 15 years, tremendous efforts have gone into robotic surgical innovation to improve perioperative morbidity for patients with bladder cancer undergoing RC," write Andrew M. Wood, MD, and Nima Almassi, MD.
Aquablation procedures for prostate cancer completed at ambulatory surgery center
FDA grants priority review to expanded indication of flibanserin in HSDD
FDA clears image-guided navigation platform for focal therapy in prostate cancer
Category III CPT code issued for Enhanced Lithotripsy System